TG Therapeutics IncTG Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This analysis of TG Therapeutics Inc employs data from across the internet and also from public documents by TG Therapeutics Inc. If you work at TG Therapeutics Inc and you would like to licence your ESG aseessment, please contact us. This assessment of TG Therapeutics Inc is prepared by All Street Sevva using cutting edge artificial intelligence.

TG Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 3.4, social score of 4.0 and governance score of 6.0.

SDG Transparency Score for TG Therapeutics Inc 
Low
0 - 3

4.8

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for TG Therapeutics Inc 
3.4

Environmental

4.0

Social

6.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1082Respiratorius AB (publ)
4.9
High
1082Shenzhen Chipscreen Biosciences Co Ltd
4.9
High
1121TG Therapeutics Inc
4.8
High
1121Heat Biologics Inc
4.8
High
1121Curis Inc
4.8
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does TG Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does TG Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does TG Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does TG Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does TG Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does TG Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does TG Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does TG Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did TG Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does TG Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has TG Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does TG Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does TG Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is TG Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does TG Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does TG Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does TG Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for TG Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. TG Therapeutics, Inc. was incorporated in 1993 and is headquartered in New York, New York.

Sorry!

Failed to process!